Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fujimoto, M.
Right arrow Articles by Naka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujimoto, M.
Right arrow Articles by Naka, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 14, No. 11, pp. 1343-1350, November 2002
© 2002 Japanese Society for Immunology


FEATURED ARTICLE OF THE MONTH

A regulatory role for suppressor of cytokine signaling-1 in Th polarization in vivo

Minoru Fujimoto1, Hiroko Tsutsui2,5, Shizue Yumikura-Futatsugi2,5, Haruyasu Ueda3, Ouyang Xingshou1, Tatsuo Abe1, Ichiro Kawase1, Kenji Nakanishi2,5, Tadamitsu Kishimoto4 and Tetsuji Naka1

1 Department of Molecular Medicine, Osaka University Graduate School of Medicine, 2–2 Yamadaoka, Suita City, Osaka 565-0871, Japan 2 Department of Immunology and Medical Zoology, and 3 Institute for Advanced Medical Sciences, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501 Japan 4 Osaka University Graduate School, 1-1 Yamadaoka, Suita City, Osaka 565-0871 Japan 5 Present address: Core Research for Evolutional Science and Technology, Japan Science and Technology Corp., Tokyo 101-0062, Japan

Correspondence to: T. Naka; E-mail: naka{at}imed3.med.osaka-u.ac.jp
Transmitting editor: L. H. Glimcher

Suppressor of cytokine signaling (SOCS)-1 is an inhibitory molecule for JAK, and its deficiency in mice leads to lymphocyte-dependent multi-organ disease and perinatal death. Crossing of SOCS-1–/– mice on an IFN-{gamma}–/–, STAT1–/– and STAT6–/– background revealed that the fatal disease of SOCS-1–/– mice is also dependent on IFN-{gamma}/STAT1 and IL-4/STAT6 signaling pathways. Since IFN-{gamma} and IL-4 are representative Th1 and Th2 cytokines respectively, here we investigated the role of SOCS-1 in Th differentiation. Freshly isolated SOCS-1–/– CD4+ T cells stimulated with anti-CD3 rapidly produced larger amounts of IFN-{gamma} and IL-4 than control cells, suggesting that these mutant T cells had already differentiated into Th1 and Th2 cells in vivo. In addition, SOCS-1+/– CD4+ T cells cultured in vitro produced significantly larger amounts of IFN-{gamma} and IL-4 than SOCS-1+/+ cells. Similarly, SOCS-1+/– CD4+ T cells produced more IFN-{gamma} and IL-4 than SOCS-1+/+ cells after infection with Listeria monocytogenes and Nippostrongyrus braziliensis respectively. Since IL-12-induced STAT4 and IL-4-induced STAT6 activation is sustained in SOCS-1–/– T cells, the enhanced Th functions in SOCS-1–/– and SOCS-1+/– mice appear to be due to the enhanced effects of these cytokines. These results suggest that SOCS-1 plays a regulatory role in both Th1 and Th2 polarizations.

Keywords: JAK, STAT, STAT-induced STAT inhibitor, suppressor of cytokine signaling-1, Th1, Th2


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
J. Horino, M. Fujimoto, F. Terabe, S. Serada, T. Takahashi, Y. Soma, K. Tanaka, T. Chinen, A. Yoshimura, S. Nomura, et al.
Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice
Int. Immunol., June 1, 2008; 20(6): 753 - 762.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
W. T. Khaled, E. K. C. Read, S. E. Nicholson, F. O. Baxter, A. J. Brennan, P. J. Came, N. Sprigg, A. N. J. McKenzie, and C. J. Watson
The IL-4/IL-13/Stat6 signalling pathway promotes luminal mammary epithelial cell development
Development, August 1, 2007; 134(15): 2739 - 2750.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Artis, A. Villarino, M. Silverman, W. He, E. M. Thornton, S. Mu, S. Summer, T. M. Covey, E. Huang, H. Yoshida, et al.
The IL-27 Receptor (WSX-1) Is an Inhibitor of Innate and Adaptive Elements of Type 2 Immunity
J. Immunol., November 1, 2004; 173(9): 5626 - 5634.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-R. Yu, R. M. Mahdi, S. Ebong, B. P. Vistica, J. Chen, Y. Guo, I. Gery, and C. E. Egwuagu
Cell Proliferation and STAT6 Pathways Are Negatively Regulated in T Cells by STAT1 and Suppressors of Cytokine Signaling
J. Immunol., July 15, 2004; 173(2): 737 - 746.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Brender, R. Columbus, D. Metcalf, E. Handman, R. Starr, N. Huntington, D. Tarlinton, N. Odum, S. E. Nicholson, N. A. Nicola, et al.
SOCS5 Is Expressed in Primary B and T Lymphoid Cells but Is Dispensable for Lymphocyte Production and Function
Mol. Cell. Biol., July 1, 2004; 24(13): 6094 - 6103.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Fujimoto, H. Tsutsui, O. Xinshou, M. Tokumoto, D. Watanabe, Y. Shima, T. Yoshimoto, H. Hirakata, I. Kawase, K. Nakanishi, et al.
Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases
Int. Immunol., February 1, 2004; 16(2): 303 - 314.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
P. Anderson, A. Sundstedt, L. Li, E. J. O'Neill, S. Li, D. C. Wraith, and P. Wang
Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in Th1 and Th2 cells
Int. Immunol., November 1, 2003; 15(11): 1309 - 1317.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. V. R. Bullen, T. M. Baldwin, J. M. Curtis, W. S. Alexander, and E. Handman
Persistence of Lesions in Suppressor of Cytokine Signaling-1-Deficient Mice Infected with Leishmania major
J. Immunol., April 15, 2003; 170(8): 4267 - 4272.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.